Your Search Results

Management of stent failures

18 May 2023 – From EuroPCR 2023

Join us as we navigate the complexities of stent failures in this session and explore the diverse strategies employed for successful outcomes: learn about the challenges posed by in-stent restenosis following chimney stenting during valve-in-valve TAVI, delve into the dilemma of underexpanded stent restenosis and weigh the...

PCI for complex coronary lesions

18 May 2023 – From EuroPCR 2023

Gain valuable insights into the management of challenging coronary lesions during PCI in this session: witness the effective treatment of in-stent restenosis through the innovative use of intravascular lithotripsy, explore the techniques employed to address non-expandable stents, discover the utility of the Guide Extension catheter system...

EuroPCR 2023 Hotlines/Late-Breaking Trials: from (N)STEMI to Chronic Coronary Syndromes (CCS)

19 May 2023 – From EuroPCR 2023

What are the most significant facts in this respect? Get the essentials by listening to the presenters review some clinical hotlines. To cite a few, Selective Intracoronary hypothermia in anterior wall myocardial infarction; real-time catheter-based microvascular obstruction detection in STEMI : results from the MOCCA I...

from (N)STEMI to Chronic Coronary Syndromes (CCS)

How to treat coronary aneurysm

18 May 2023 – From EuroPCR 2023

Treating coronary aneurysms requires careful consideration and depends on several facors such as specifics characteristics of the aneurysms and patient’s conditions. Learn more the way to treat them throught this series of cases: massive thrombosis of an RCA aneurysm ; new insight toward understanding WOVEN like...

The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial

25 Oct 2023

Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...

Author

Nicola Ryan

Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement System in High-Risk Patients with Symptomatic Severe Native Aortic Regurgitation (ALIGN-AR)

The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation

01 Sep 2025

Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.

Author

Chiara De Biase

The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]

3646 results for «538»

3646 results